Look-Alike, Sound-Alike (LASA) Medication Safety: A Guide for Care Staff

Some of the most serious medication errors have nothing to do with a wrong diagnosis or a rushed decision - they happen because two drug names look almost identical on a shelf, or sound almost identical read aloud over the phone. Look-alike, sound-alike (LASA) medications are a well-recognised patient safety risk, and one that good systems and simple habits can significantly reduce.

What are look-alike, sound-alike medications?

LASA medications are pairs or groups of drugs whose names, packaging, or both are similar enough to cause confusion - for example, similarly spelled drug names, or different medications packaged in similar boxes at similar shelf positions. The risk isn't limited to unfamiliar drugs; well-known medications can be mixed up too, particularly under time pressure or in poor lighting.

The World Health Organization has published dedicated guidance on this exact problem, describing medication safety for look-alike, sound-alike medicines as a recognised global patient safety priority, noting that confusion between similarly named or packaged medicines contributes to a meaningful share of preventable medication errors worldwide.

Why these errors happen

LASA errors are rarely about carelessness. They tend to cluster around a predictable set of conditions: verbal or handwritten orders where names sound alike, similar packaging stored close together, staff working under time pressure or interruption, and unfamiliar drug names encountered during agency shifts or new starters still learning a ward's stock. Research summarised by the Pharmaceutical Journal has also highlighted how electronic prescribing systems, while reducing some risks, can introduce new ones - for example, drop-down lists where similar drug names sit close together and an easy misclick goes unnoticed.

Practical steps care and healthcare staff can take

• Read medication names in full, out loud where checking with a colleague, rather than relying on the first few letters or general shape of the packaging
• Use independent double-checking for high-risk medications, where a second person verifies the drug, dose and resident separately rather than simply confirming what the first person says
• Store LASA pairs separately where possible, or clearly flag them if they must be stored near each other
• Be extra cautious with verbal or telephone orders - repeat back the full drug name, dose and resident details before acting
• Report any near-miss, not just actual errors, since near-misses reveal the same underlying risks before harm occurs
• Pay close attention when using electronic prescribing or ordering systems, particularly with drop-down or auto-complete lists

Why near-miss reporting matters so much here

Because LASA errors are a systems problem as much as an individual one, reporting near-misses is one of the most powerful tools a care setting has. A near-miss report - "I nearly gave the wrong one because they're stored next to each other" - can prompt a simple fix, like moving stock or adding a warning label, that prevents a future error entirely. Treating near-miss reporting as valuable rather than something to avoid because it feels like admitting a mistake is a genuine culture shift worth investing in.

Connecting this to wider medication safety practice

LASA awareness works best as part of a broader culture of careful, unhurried medication management, rather than a stand-alone rule. Teams that already follow strong general medication safety practices - checking the right resident, right drug, right dose, right route, right time - are naturally better placed to catch LASA-specific risks too, because slowing down and checking properly is already part of how they work.

Simple system changes that help

Beyond individual vigilance, small environmental and process changes make a measurable difference. Tall man lettering - capitalising the distinguishing part of a drug name, such as "predniSONE" versus "prednisoLONE" - is widely used in packaging and prescribing systems specifically to draw the eye to the part of the name that differs. Physically separating commonly confused pairs on medication trolleys and shelves, adding warning stickers to high-risk look-alike stock, and reviewing incident and near-miss reports regularly as a team to spot local patterns are all low-cost changes that compound over time into a meaningfully safer system.

Frequently asked questions

Are LASA errors only a risk with unfamiliar medications? No - even well-known, frequently used medications can be involved if their names or packaging are similar to another drug in regular use.

What's the single most effective way to reduce LASA errors? No single measure eliminates the risk entirely, but consistently reading full drug names, using independent double-checks for high-risk medications, and reporting near-misses together make a significant difference.

Should agency or new staff be treated differently for LASA risk? They're often at higher risk simply through unfamiliarity with local stock and storage, so extra orientation to commonly confused medications on that specific ward or unit is worth building into induction.

Reducing look-alike, sound-alike medication errors is one of the most achievable patient safety wins available to a care team. Build this awareness with CPD courses for care and healthcare staff.